Exp Mol Med.  2017 Apr;49(4):e323. 10.1038/emm.2017.5.

TET family dioxygenases and DNA demethylation in stem cells and cancers

Affiliations
  • 1Department of Biological Sciences, Chonbuk National University, Jeonju, Korea.
  • 2Division of Signaling and Gene Expression, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA.
  • 3Department of Pharmacology and Moores Cancer Center, University of California at San Diego, La Jolla, CA, USA.
  • 4Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.
  • 5Center for Genomic Integrity, Institute for Basic Science (IBS), Ulsan, Korea. mgko@unist.ac.kr
  • 6School of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan, Korea.

Abstract

The methylation of cytosine and subsequent oxidation constitutes a fundamental epigenetic modification in mammalian genomes, and its abnormalities are intimately coupled to various pathogenic processes including cancer development. Enzymes of the Ten-eleven translocation (TET) family catalyze the stepwise oxidation of 5-methylcytosine in DNA to 5-hydroxymethylcytosine and further oxidation products. These oxidized 5-methylcytosine derivatives represent intermediates in the reversal of cytosine methylation, and also serve as stable epigenetic modifications that exert distinctive regulatory roles. It is becoming increasingly obvious that TET proteins and their catalytic products are key regulators of embryonic development, stem cell functions and lineage specification. Over the past several years, the function of TET proteins as a barrier between normal and malignant states has been extensively investigated. Dysregulation of TET protein expression or function is commonly observed in a wide range of cancers. Notably, TET loss-of-function is causally related to the onset and progression of hematologic malignancy in vivo. In this review, we focus on recent advances in the mechanistic understanding of DNA methylation-demethylation dynamics, and their potential regulatory functions in cellular differentiation and oncogenic transformation.


MeSH Terms

5-Methylcytosine
Cytosine
Dioxygenases*
DNA*
Embryonic Development
Epigenomics
Female
Genome
Hematologic Neoplasms
Humans
Methylation
Pregnancy
Stem Cells*
5-Methylcytosine
Cytosine
DNA
Dioxygenases
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr